Intensity Therapeutics, Inc. Common stock (NYSE: INTS) — Healthcare · Share Price, Chart & Market Data
About: Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.15 (-0.39%)
INTSIntensity Therapeutics, Inc. Common stock
Loading watchlist status…
Trade INTS now
Intensity Therapeutics, Inc. Common stock share price
INTS price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
30 Apr, 4:21 am GMT+0
INTS price performance
-3.377%
5D
-9.331%
1M
-49.386%
YTD
-65.69%
1Y
INTS price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
30 Apr, 4:21 am GMT+0
INTS details
INTS Market Signals